Early cholesterol-lowering to help reverse artery plaque
Part of Heart & circulation clinical trials.
This trial studies whether starting strong cholesterol-lowering treatment early can reduce or reverse plaque in the arteries. It may help protect the heart over time, especially for people with inherited high cholesterol.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with familial hypercholesterolemia (inherited high cholesterol) in one gene copy (heterozygous)
- You are an adult age 18 to 50
- Your LDL (“bad cholesterol”) is higher than 100 mg/dL (over 2.6 mmol/L) at the start of the study
- Your kidney function is not severely reduced (eGFR is 30 or higher)
- You have not had past heart or blood-vessel events from plaque (like heart attack or stroke)
- You do not have atrial fibrillation, an irregular heart rhythm
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether two medicines, a statin and colchicine, can slow or stop early heart artery plaque from growing in people who have mild plaque but no heart disease symptoms yet. It uses special CT scans to measure plaque over 2 years.
This trial tests whether higher doses of cholesterol-lowering medication (statins) can slow down plaque buildup in the heart arteries of younger and middle-aged adults with stable chest pain. It may help prevent heart attacks and the need for procedures like stents.
This trial aims to identify kids and teens who may have inherited high cholesterol (especially LDL) and may be at higher risk for early heart artery disease. It may help families learn about their risk and ensure the right follow-up and treatment plan.
This study tests whether starting cholesterol-lowering treatment early can prevent heart attacks in people aged 30-50 who already have early signs of artery plaque but no history of heart disease.
This study tests whether quickly increasing cholesterol-lowering medication can reduce the risk of another heart attack or stroke. It is for people who have heart disease from blocked arteries.
This trial looks at how treating or managing conditions like diabetes, prediabetes, obesity, kidney disease, or high cholesterol affects artery plaque over time. It may help researchers find ways to slow plaque buildup and related heart risks.
Hear when a new Coronary Artery Disease Progression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.